electroCore to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum
2023年11月7日 - 10:00PM
electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic
medicine and wellness company, announced today that Company CEO,
Dan Goldberger, is scheduled to attend the Canaccord Genuity
MedTech, Diagnostics and Digital Health & Services Forum taking
place at the Westin NY Grand Central on November 16, 2023.
1x1 Meetings
electroCore will host 1x1 investor meetings on November 16,
2023. Please contact your Canaccord representative to schedule a
1x1 meeting.
About electroCore, Inc.electroCore, Inc. is a
commercial stage bioelectronic medicine and wellness company
dedicated to improving health through its non-invasive vagus nerve
stimulation (“nVNS”) technology platform. Our focus is the
commercialization of medical devices for the management and
treatment of certain medical conditions and consumer product
offerings utilizing nVNS to promote general wellbeing and human
performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.
Contact:ECOR Investor Relations(973)
302-9253investors@electrocore.com
electroCore (NASDAQ:ECOR)
過去 株価チャート
から 5 2024 まで 6 2024
electroCore (NASDAQ:ECOR)
過去 株価チャート
から 6 2023 まで 6 2024